Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Dividend History VALN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Dividend Analytics VALN

Max Ratio

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Forward Annual Dividend Yield
Consecutive Years
Forward Annual Dividend – USD
Consistent Years
Dividend CAGR 3Y
Continuous Dividends
Dividend CAGR 5Y
Payout Ratio TTM
Dividend CAGR 10Y
Ex Dividend Date

Valneva SE ADR

VALN
Current price
5.90 USD -0.005 USD (-0.08%)
Last closed 5.74 USD
ISIN US92025Y1038
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 494 035 360 USD
Yield for 12 month -18.13 %
1Y
3Y
5Y
10Y
15Y
VALN
21.11.2021 - 28.11.2021

Valneva SE, a specialty vaccine company, develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet needs. It offers IXIARO, an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis; DUKORAL, an oral vaccine for the prevention of diarrhea caused by Vibrio cholera or heat-labile toxin producing enterotoxigenic Escherichia coli bacterium; and IXCHIQ/ VLA1553, a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also develops VLA15, a vaccine candidate against Borrelia, the bacterium that causes Lyme disease; S4V2, a tetravalent bioconjugate vaccine candidate against shigellosis, a diarrheal infection caused by Shigella bacteria; VLA1601, a vaccine candidate targeting the Zika virus, a mosquito-borne viral disease; VLA1554, a vaccine candidate targeting human metapneumovirus; VLA84, a vaccine candidate targeting the prevention of primary symptomatic clostridium difficile infection; and VLA2112, a vaccine candidate to treat patients with epstein-barr virus. It sells its products in the United States, Canada, Germany, Austria, Nordics, the United Kingdom, France, rest of Europe, and internationally. The company was founded in 1998 and is based in Saint-Herblain, France. Address: 6 rue Alain Bombard, Saint-Herblain, France, 44800

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

13.37 USD

P/E Ratio

Dividend Yield

Financials VALN

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Key Figures VALN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021

Current Year

+199 532 872 USD

Last Year

+180 864 245 USD

Current Quarter

+57 928 519 USD

Last Quarter

+62 292 690 USD

Current Year

+83 588 763 USD

Last Year

+62 170 319 USD

Current Quarter

+30 815 120 USD

Last Quarter

+30 250 331 USD
EBITDA -135 784 752 USD
Operating Margin TTM -12.11 %
Price to Earnings
Return On Assets TTM -19.19 %
PEG Ratio
Return On Equity TTM -44.11 %
Wall Street Target Price 13.37 USD
Revenue TTM 186 056 992 USD
Book Value 1.14 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 50.30 %
Dividend Yield
Gross Profit TTM 10 671 000 USD
Earnings per share -1.32 USD
Diluted Eps TTM -1.32 USD
Most Recent Quarter I 2025
Quarterly Earnings Growth YOY
Profit Margin -43.21 %

Stock Valuation VALN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 666.67
Enterprise Value Revenue 2.50
Price Sales TTM 2.66
Enterprise Value EBITDA 26.94
Price Book MRQ 2.39

Technical Indicators VALN

For 52 Weeks

3.62 USD 8.66 USD
50 Day MA 6.23 USD
Shares Short Prior Month 2 094
200 Day MA 5.85 USD
Short Ratio 0.030
Shares Short 2 419
Short Percent